Today, cardiac contractility in mice is exclusively measured under anaesthesia or in sedated animals because catheters available are too rigid to be used in the awake mice. We have therefore developed a new catheter (Pebax03) to measure cardiac contractility in conscious mice. In this study we have evaluated the accuracy and utility of this new catheter for assessment of cardiac contractility in anaesthetized and conscious mice. Using a balloon pop test, the pebax catheter with an inner diameter of 0.3 mm was found to exhibit a high natural frequency, a low damping coefficient and a flat frequency of up to 50.5±0.6 Hz. Under anaesthesia (0.5 or 1.0% halothane), no difference was found in heart rate (HR), left ventricular systolic pressure (LVSP), LVdP/dt max , LVdP/dt min , ejection time (ET), and isovolumic relaxation (τ) when measured either with the 1.4F Millar or the pebax 03 catheter. However, when HR, LVSP, LVdP/dt max and LVdP/dt min were recorded with the pebax catheter in awake mice, values were significantly higher and ET and τ lower than under anaesthesia suggesting a major impact of anaesthesia on these parameters. The pebax catheter was also used in a normotensive one-renin gene mouse model of cardiac hypertrophy induced by DOCA and salt. In this model, DOCA/salt induced a severe decrease in cardiac contractility in the absence of changes in blood pressure. These data demonstrate that cardiac contractility can be measured very accurately in conscious mice. This new device can be of great help to investigate cardiac function in normal and genetically engineered mice.
Introduction
During recent years, gene manipulated mice have become a subject of rapidly growing interest in cardiovascular research (1, 2, 17, 20, 21, 23, 27, 35, 36) . Quite naturally, this has created a strong need for accurate assessment of cardiovascular variables in mice. Whereas the accurate monitoring of blood pressure and heart rate in the awake mouse has been established quite rapidly in many laboratories, the determination of cardiac function presents a greater difficulty (34). This is all the more regrettable as several gene manipulated mouse models of cardiac hypertrophy and cardiac failure have become available (5, 15, 22, 24, 35, 39) . So far, cardiac contractility has been measured almost exclusively using the 1.4F Millar catheter (5, 8, 9, 10, 11, 15, 17, 39) , but because of its stiffness this measuring system can only be used in anaesthetized mice.
Moreover, because of their fragility and costs, Millar catheters are not used as frequently as they could in experimental conditions. This is relevant given the well known effect of anaesthesia on cardiac function in large mammals (13, 28, 38) and mice (9, 10, 18, 27 ).
The present study was undertaken to assess a custom made, low cost pebax 03 catheter that can be used in awake mice to measure cardiac contractility. The results clearly demonstrate that under anaesthesia the pebax 03 yields identical results to those obtained with the 1.4F Millar system but in contrast to this latter, the pebax 03 catheter enables to measure cardiac contractility in awake mice. Our data also confirm that anaesthesia profoundly alters the cardiac contractility of mice and show that mineralocorticoids decrease cardiac contractility in conscious mice independently of blood pressure.
Methods

Characterization of the pebax catheter
The pebax catheter ( Figure 1 and Figure 2 ) was put together in the following way: eighteen mm of pebax tubing (Medical Extrusion Technology, Inc, CA, USA) was joined at the tip to 1 mm of silicone tubing (inner/outer diameter [ID/OD]: 0.30 /0.64 mm) which prevents the pebax tubing from touching the ventricular wall during contraction ( Figure 1A ). At the other end, the pebax catheter is connected to a hydraulic pressure transport line consisting of 12 cm of PE50 tubing (SIMS Portex Ltd, CT21 6JL, UK) joined to 7 cm of silicone tubing (ID/OD: 0.51/0.94 mm, Ulrich AG, St. Gallen, Switzerland). This allows the catheter to be exteriorized and attached to the back of the mouse. The line is connected to a pressure transducer (World Precision Instruments, Inc., Sarasota FL, USA) and a computerized data-acquisition system (Notocord HEM 3.1 software, Croissy sur Seine, France) ( Figure 2 ). The length of the whole pebax catheter setup is only 25 cm. It is filled with 0.5 ml of degassed saline containing heparin (300 UI/ml). Meticulous care has to be taken to ensure that the system is always free of air bubbles throughout the experimental period.
The natural frequency (f) and damping coefficient (β) of the pebax catheter pressure transducer system were determined using a transient method ("balloon-pop test") adapted from Gabe (6) .
To do so, a pebax catheter was passed through a stopcock into a 12 cm plexiglas cylinder (ID: 2.5 cm) filled with degassed saline and the top of the cylinder was covered and held with a rubber-band and -membrane obtained from a surgical glove. The balloon inflated pressure was held at 65∼75 mmHg. The membrane was then popped with a match, which caused the pebax catheter pressure transducer system to oscillate at its dampened natural frequency and these pressure changes in the catheter system were recorded by the Notocord HEM 3.1 software at a sampling rate of 10,000 Hz. Considering the diameter effect on the dynamic characteristics, two sizes of pebax catheters were tested, a pebax 02 catheter (ID/OD of pebax tubing: 0.20mm/0.48mm) and a pebax 03 (ID/OD of pebax tubing: 0.30mm/0.48 mm).
Mice and left ventricular (LV) catheterisation
Fifty seven male C57BL/6J mice (∼30g) and ten male N 5-6 -129OlaXC57BL/6J backcrossed mice (∼30g), obtained from the Institute of Pharmacology, University of Lausanne, Switzerland, treated either with DOCA-salt (1% NaCl) or tap water (37) were used in the present study.
Mice were anaesthetized via inhalation of 1~2% halothane mixed with oxygen. The right carotid artery was exposed for a length of approximately 5 mm. A 1.4F Millar pressure catheter (Millar Instruments Co, Houston) or the self-made pebax 02 or 03 catheter was advanced into the left ventricle through the right carotid artery. The correct position of the catheter tip in the left ventricle was then confirmed by the waveform of the left ventricular pressure (LVP) visualized on a Hewlett Packard monitor. The arterial line was connected to the computerized dataacquisition system to record heart rate (HR), LVP, LVdP/dt max and LVdP/dt min , ejection time (ET), and isovolumetric relaxation (τ) at a sampling rate of 1000 Hz. A venous catheter (PE10/Silicone catheter), made of 4 mm of PE10 tubing (SIMS Oortex Ltd, UK) joined to 7 cm of silicone tubing (ID/OD: 0.51 mm/0.94 mm, Ulrich AG, St. Gallen, Switzerland) and filled with saline containing heparin (300 U/ml), was inserted into the left jugular vein for drug administrations. For monitoring of LV hemodynamic signals in the conscious state, the pebax catheter (silicone tubing) was closed by inserting a copper pin and subcutaneously tunnelled to exit the skin on the back of the mouse where it was attached with dental cement and a piece of scotch. The mouse was then free to move around in the cage and allowed 3~4 hours to recover from the halothane anaesthesia. After connecting the catheter to the pressure transducer, and a stabilization period of 30 min. LV hemodynamic signals were simultaneously recorded for 10~15 minutes and saved for later analysis.
Comparison of Millar and Pebax catheters
In order to compare the two methods under identical conditions, either an 1.4F Millar or a pebax 03 catheter was alternatively advanced into the same left ventricle of the same individual C57BL/6J mouse to record and analyse HR, LVP, LVdP/dt max , LVdP/dt min , ET, and τ for 5∼10 minutes during an inhalation of 0.5% halothane. Afterwards, the mouse was kept in the same position with the same dose of halothane (0.5%). The right carotid artery together with the catheter was hold by a self-closing tweezer (Dumont SA, Montignez, Switzerland), the silk 3/0 made knots on the right carotid artery were carefully released and the catheter (Millar or pebax03) was pulled off. Meanwhile, the bleeding was prevented by upstream stretching a pre- All experiments were carried out following the principles in the care and use of animals and were accepted by the local veterinary services.
Statistical analysis
Average values of HR, LVP, LVdP/dt max and LVdP/dt min , ET, and τ were determined for 120 seconds from the sampling data. Results are expressed as mean ± SEM and comparisons be-tween groups were analysed by a paired and unpaired Student's t test or by a one-way ANOVA followed by a Newman-Keuls test. A p value < 0.05 was considered statistically significant.
Results
Dynamic characteristics of the pebax catheter
Six pebax 03 (P03) and 5 pebax 02 (P02) catheters were characterized with the "Balloon pop test" (see Figure 1B for an example). Natural frequency (f) and damping coefficient (β) of the pebax 03 catheter, f P03 and β P03 were 202±2Hz and 0.058±0.004 respectively, and flat frequency, f P03-flat was up to 50.5±0.6Hz calculated by f P03 x cut-off frequency (f cut , 0.25, Figure   1C ). In contrast, f P02 and β P02 were 162±2Hz and 0.134±0.004 respectively, and f P02-flat , 40 .5±0.5Hz (p<0.0001 versus pebax 03 catheters). While LVSP, HR, and ET were not affected by catheter size, LVdP/dt max , LVdP/dt min , and τ were reduced by 40% in conscious mice cathe- Table 2 . As shown, there was no difference between the two catheters. Figure 4A depicts LVP tracings obtained with the two catheters. It is clearly apparent that the two pressure curves are identical and that the detailing of the curve obtained with the pebax 03 catheter is at least as good as that obtained with the 1.4F Millar catheter.
Further evidence that the two catheter systems yield identical results is provided in Figure 4B :
When the timed pressure points of different cardiac cycles obtained with the two catheter systems are related a regression line not different from identity is observed.
In a further experiment, dose-response curves for isoproterenol were established in 12 mice under halothane 0.5% anaesthesia. Figure 5 illustrates the observed changes in cardiac contractility. It is again evident that the two catheters yield identical results when blood pressure and heart rate are changed acutely.
b) Effect of anaesthesia on LV hemodynamics
The effects of two doses of halothane on cardiac contractility are shown in Table 3 . As shown in the table, reducing the dose of halothane from 1 to 0.5%, HR and LVSP progressively rose and the absolute values of LVdP/dt max and LVdP/dt min were almost doubled, whereas ET and τ were significantly shortened (p<0.01, 0.5% versus 1% halothane). These dose-dependent changes in LV hemodynamics induced by anaesthesia were reversible when the dose of halothane was returned to 1%. This already support the evidence that LV hemodynamics are profoundly altered by the anaesthesia. Notwithstanding, the data obtained with the two catheter systems were again identical.
When LV hemodynamics were measured again in 9 mice with a pebax 03 catheter system in place, 3 to 4 hours following anaesthesia in the conscious state, HR, LVSP and absolute values of LVdP/dt max and LVdP/dt min were substantially higher and ET and τ markedly shortened versus the data obtained with the same catheter system under anaesthesia. The data of all 9 animals are depicted in Table 3 .
Cardiac contractility in conscious normotensive mice with DOCA-salt induced cardiac hypertrophy
Recently it was demonstrated that N 5-6 (129Ola× C57BL/ 6J) mice harbouring only one renin gene when treated with DOCA and salt develop cardiac hypertrophy without hypertension (37) . In the present experiments, the pebax 03 catheter system was thus used in conscious N 5-6 (129Ola× C57BL/ 6J) mice previously maintained on DOCA (21.3±0.22µg/h) and saline for 3 months. The data are summarized in Table 4 . The ratio of cardiac to body weight, an index of cardiac hypertrophy, was again found to be increased when compared to matched controls, whereas blood pressure was not different. Absolute values of LVdP/dt max and LVdP/dt min were significantly reduced in DOCA-salt treated mice. Similarly, the time constant of LV isovolumetric relaxation (τ) was markedly prolonged, while the ejection time (ET) was not changed. Thus, using this new methodology in awake mice, a clear defect in cardiac contractility could be demonstrated in this normotensive mouse model of cardiac hypertrophy.
Discussion
With the general availability of transgenic methodology, the mouse has become an important experimental animal also for cardiovascular research. This has made it necessary to adapt the various measuring techniques to this small animal. So far, the measurement of cardiac contractility in the mouse was only possible with the Millar catheter but the Millar catheter cannot be used in the conscious state and renders anaesthesia or at least a sedation mandatory (8) . As a result, all data available so far on cardiac contractility in mice were obtained under experimental conditions known to substantially alter most cardiovascular parameters (34). In addition, Millar catheters are quite expensive and cannot be used frequently in physiological studies.
In the present paper a new, custom made, low cost catheter is presented which allows to obtain LV hemodynamic measurements in the awake mouse and to derive the key contractility parameters. The data demonstrate that the system exhibits an adequate frequency response and damping coefficient in vitro and under anaesthesia yields results that are identical to those obtained with the Millar catheter. However, and maybe not surprisingly, results of further experiments confirm that anaesthesia profoundly modifies the cardiac contractility of the mice.
This technique was then used in additional experiments to investigate the LV contractility in mice with cardiac hypertrophy induced by the administration of DOCA and 1%NaCl. The results illustrate a markedly decreased contractility in these animals with hypertrophied hearts.
Given all these data it would seem preferable that in the future, measurements of cardiac contractility in mice are made in the awake state.
A fluid-filled catheter system with an inadequate dynamic response will cause phase and amplitude errors resulting in over-or underestimation of LVPs. To avoid this problem, it is, generally believed that a fluid-filled catheter system must have a frequency response that is flat up to 5 times the source frequency to be recorded and in addition must exhibit a low damping (7, 25, 26, 30, 38) . The natural frequency of a fluid-filled catheter varies with its radius and stiffness and inversely with its length. The damping coefficient is proportional to its length and inversely related to its radius and stiffness (25, 26, 38) . Therefore, to obtain a high frequency response and a low damping, the catheter length should be short and the internal diameter of the catheter must be as large as possible. With this strategy, the pebax 02 and 03 catheters, were produced and characterized in our laboratory.
As expected the pebax 03 catheter turned out to have a high natural frequency, a low damping coefficient and a flat frequency up to 50 Hz, which should be high enough for accurate analysis of LVP with a frequency (HR) of about 10Hz in conscious mice. In contrast, the pebax 02 catheter, had a flat frequency up to 40 Hz. As a consequence, when both pebax catheters were To investigate the role of anaesthesia on cardiac contractility, mice inhaled different doses (1% and 0.5%) of halothane, and LV hemodynamic parameters were again determined either with the Millar or the pebax 03 catheter system. All the variables were markedly altered by changing the dose of halothane and these dose dependent changes were reversible. Again, no difference between the two recording methods was observed. In marked contrast however, when HR, LVSP, and absolute values of LVdP/dt max and LVdP/dt min were again measured in conscious mice, they were substantially higher and ET and τ shortened. This may not come as a complete surprise since anaesthesia has been shown repeatedly to substantially alter hemodynamic variables (3, 4, 13, 18, 19, 28, 30, 33, 39) . Table 5 summarized the data published in several papers in which cardiac hemodynamics have been measured in anaesthetized mice. While our LV hemodynamic data obtained under anaesthesia with the pebax 03 catheter are in full agreement with the previous reports, the parameters obtained with the same catheter in the awake state are clearly different. As a consequence, experiments exploring cardiovascular physiology or pharmacology in intact animals should be carried out in the awake state whenever possible in order to avoid erroneous results. Unfortunately, so far this requirement could not be fulfilled in mice with the Millar catheter due to its rigidity and cost. The present results obtained with the pebax 03 catheter in awake mice set a new benchmark for cardiac contractility in mice and underline once more the importance that observations be made in the conscious state.
Similar to previous studies (11, 14, 16, 17) , we found that many of the LV hemodynamic parameters such as LVdP/dt max LVdP/dt min and τ are related to heart rate. Furthermore, LVSP was correlated with LVdP/dt max and LVdP/dt min which provides further evidence that anaesthesia-induced hypotension and bradycardia distort LVdP/dt max and LVdP/dt min . ET was so closely correlated with HR (r=0.93, p<0.0001) that it seems to be almost entirely determined by HR.
Finally, the pebax 03 catheter was used in a one-renin gene mouse model of cardiac hypertrophy without hypertension induced by DOCA and salt (37) to assess cardiac contractility. After 3 months of DOCA and salt administration the ratio of heart to body weight was increased compared to the control, as reported previously (37) . It was now possible to show that absolute values of LVdP/dt max and LVdP/dt min were more than 50% decreased and τ, 3 times longer when compared to the control animals. These data clearly demonstrate that these DOCA and salt treated mice exhibit decreased cardiac contractility even in the absence of hypertension, suggesting that pressure independent factors such as DOCA, salt, hypokalemia or cardiac hypertrophy per se may be the cause of this decrease in cardiac contractility as suggested in other animal models (32).
In conclusion, these studies clearly demonstrate that anaesthesia markedly alters cardiac contractility and causes dose dependent changes in LVdP/dt max and LVdP/dt min. With our new pebax 03 catheter with a natural frequency of ~200 Hz, a damping factor of 0.06, and a flat frequency up to 50 Hz LV, hemodynamics can now be accurately measured in conscious mice. An additional advantage of this new catheter is the fact that it costs a fraction of the Millar probe. In contrast to some Millar catheters, the pebax catheter does not enable to measure pressure-volume relationships. However, even these latter can not be obtained in of mice will be measured in the awake state. This new device can be of great help to investigate cardiac function in normal and genetically engineered mice. 
